Background Most treatments for postpartum haemorrhage (PPH) lack evidence of
effectiveness. New innovations are ubiquitous but have not been synthesized for ready …

OBJECTIVE: To evaluate red blood cell use during delivery in patients with placenta accreta
spectrum. DATA SOURCES: We searched MEDLINE, EMBASE, CINAHL, Cochrane Central …

Objective: Placenta Accreta Spectrum (PAS) affects approximately one in a thousand
deliveries. Very few studies evaluated PAS risk factors based on their location. In this study …

Objective To report the results of prophylactic use of intraoperative temporary internal iliac
arterial occlusion by Bulldog clamps in patients clinically diagnosed with abnormally …

Introduction Placenta accreta spectrum (PAS) is associated with a multitude of maternal and
fetal complications. Events related to its management have resulted in significant …

BACKGROUND Cesarean hysterectomy for placenta accreta spectrum disorder may be
associated with severe hemorrhage because of placental invasion of the myometrium and …

Objective To assess (i) clinical and pregnancy characteristics,(ii) patterns of surgical
procedures, and (iii) surgical morbidity associated with cesarean hysterectomy for placenta …

Background Placenta accreta syndrome (PAS) may led to heavy blood loss and maternal
death. Here we analyzed the main risk factors of PAS+ pregnancies and its complications in …

Objective To evaluate whether the implementation of our surgical approach, referred to in
the text as Linear Cutter Vessel Sealing System (LCVSS) technique, will improve …

Background Placenta accrete remains a problem in developing countries. The incidence
rate has increased over the last 30 years accompanied by the risk of maternal death …